Generic Giants Ask Fed. Circ. To Nix Vimpat Patent
Actavis Inc., Mylan Pharmaceuticals Inc. and other drug companies teamed up Tuesday for an assault on UCB Inc.'s patent for the anti-convulsant Vimpat at the Federal Circuit, seeking the chance to...To view the full article, register now.
Already a subscriber? Click here to view full article